ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

The Future of Pathology is Digital

3rd World Pathology Conference

Abdulrahman Theyab

Steve D. Barbee, CEO, CROPath USA

ScientificTracks Abstracts: J Clin Exp Pathol

Abstract
As the field of pathology has quickly changed in the past few years, digital pathology has emerged as permanent and effective frontier. As digital pathology continues to grow at a fast past, many organizations and experts are working to move the equipment, acceptance, regulation and innovation forward in a positive direction. With the complex integration of technology, software, hardware, medical needs and more, various experts from differing backgrounds are required to create these innovations and ideas. Often these experts and their efforts are being conducted independently of one another with little or no cross discipline discussion. As a way to bring together various ideas, thought leaders, innovators and others interested and involved in the field of digital pathology, we created a new audio podcast show, called Digital Pathology Today�. The independent interview style show, Digital Pathology Today� was launched in October 2020, to create a platform for the various players involved in the field of digital pathology to educate, inform, discuss and evaluate the next steps in digital pathology. Guests were selected based on their knowledge, experience, expertise in various areas involved with the development, implementation, use, study and history of artificial intelligence, machine learning and digital pathology. Each guest was briefed and provided advance discussion points to optimism their short time on the program. Audio-only interviews were recorded remotely, then edited and sound engineered to create maximum voice and audio quality. New episodes were released approximately the same time each week directly to the Digital Pathology Today� website and simultaneously to all major podcast services. Guests appeared free of charge and without payment. The show is funded through the support of sponsors. Digital Pathology Today� received 50,000+ downloads of the first seven months.
Biography

Steven D. Barbee has worked within the pathology industry for over 18 years. Mr. Barbee is the President of JAV Advisors Corp and CEO of CROPath, LLC. Additionally, Mr. Barbee is the President of Digital Pathology TodayTM & MagPie Diagnostics, LLC (CRO for digital pathology firms). Mr. Barbee served as President of DigiPath Corp since 2012, a digital slide scanner company. Prior to joining DigiPath, Mr. Barbee was Vice President of Sales, International, and Government Affairs at BioImagene, Inc., a digital pathology firm acquired by Roche Corporation in 2010. Before joining BioImagene, Mr. Barbee was Vice President of Sales and Marketing at Trestle Corporation, a digital pathology firm acquired by Clarient, Inc in 2006. Prior to the digital pathology sector, Mr. Barbee served in various general and sales management positions within telecommunication companies, including Zyan Communications, Level 3 Communications, ICG Telecom Group, and AT&T.

Top